Your body speaks long before symptoms do. Quiet signals. Subtle shifts.
Early insight, before symptoms begin. Non-invasive. Accessible. Grounded in science.
Globally proven. Built for India. Simple prevention.
From screening to insight. Structured, step-by-step workflow.
Women-led. Grassroots access. Extending screening beyond clinics.
From individual signals to population understanding. Building India’s cancer evidence base.
Clarity is power. Supportive, not frightening.
Accuracy. Real-world evidence. India-specific baseline.
Partner, not product. Future of early detection. India-led innovation.
15k+ clinical screenings
Guided, Delivered & Integrated within a framework of clinical oversight at each stage, across the process.
Structured coordination across sample collection, clinical processes into the screening workflow.
About Us
We are building a structured cancer screening and Real-World Evidence (RWE) platform integrating clinical screening, laboratory diagnostics, and next-generation sequencing (NGS), supported by clinical oversight to generate population-level insights into cancer biology across real-world patient journeys.
Screening Plan
Clinician-supported access non-invasive screening options designed for clinical oversight, using structured sample collection workflows for early biological insight.
Integrated Expertise
working together to support structured screening, validated workflows, and Real-World Evidence (RWE) generation.
Science
Medical
FAQ’s
No. This is not a diagnostic test and does not confirm or rule out any medical condition. It is for screening and awareness.
Early insight refers to understanding general biological patterns that may change over time. It supports awareness, not diagnosis.
Kits are collected or distributed through authorised healthcare partners, clinics, or approved outreach teams. Sample return follows a supervised and structured process.
These signals reflect variations in biological patterns over time and should be interpreted within clinical context, not as medical findings.
We analyse biological markers from your sample to observe general molecular and physiological patterns. This supports structured screening, not diagnosis.
No, we do not offer a free version or trial. The screening service is delivered through authorised healthcare partners as part of a clinically supervised process. This ensures that sample collection, analysis, and interpretation are handled within appropriate healthcare pathways.
Payment methods or subscription-based vary depending on the authorised healthcare partner or clinic through which the screening is accessed. Accepted options typically include standard digital payments and card transactions processed within the partner healthcare system.
This depends on individual or clinician guidance. The system supports flexible screening rather than fixed intervals.
You can request a test through authorised healthcare partners or participating clinics. Once requested, a screening kit is provided and sample collection is guided through clinical pathways.
This depends on individual or clinician guidance. The system supports flexible screening rather than fixed intervals.
Anonymised screening data contributes to a structured RWE framework, supporting population-level health insights over time.
Licensed clinicians provide oversight, ensuring responsible interpretation within real-world healthcare settings and ethical and regulatory boundaries.
Yes. The process is non-invasive comfortable and designed for simple home collection using swab or stool kits, under clinical guidance where required.
Accredited laboratories perform validated analysis using standardised methods, including molecular and genomic techniques such as NGS.
Integrated leadership across clinical, scientific, research, and community screening initiatives
Scientific & Laboratory Advisor
Lead Scientific Advisor
Founder & Platform Lead
Chief Strategy Officer
Financer
Healthcare collaboration
National Clinical Advisor
Our Latest News & blog
